Competing interests.
作者信息
Sharpe Virginia A, Gurian-Sherman Doug
出版信息
Nat Biotechnol. 2003 Oct;21(10):1131. doi: 10.1038/nbt1003-1131a.
PMID:14520389
Abstract
摘要
相似文献
1
Competing interests.利益冲突。
Nat Biotechnol. 2003 Oct;21(10):1131. doi: 10.1038/nbt1003-1131a.
2
Ghostbusters should only bust ghosts.捉鬼敢死队只应捉鬼。
Nat Biotechnol. 2008 Oct;26(10):1067-8. doi: 10.1038/nbt1008-1067.
3
Nothing to see here.没什么可看的。
Nat Biotechnol. 2008 May;26(5):476. doi: 10.1038/nbt0508-476.
4
Re: Regulatory Toxicology and Pharmacology.关于：《监管毒理学与药理学》
Int J Occup Environ Health. 2003 Oct-Dec;9(4):390; author reply 390-1.
5
[Publication ethics: regulation of financial conflicts of interests in medical journals].[出版伦理：医学期刊中经济利益冲突的规范]
Lege Artis Med. 2011 Jan;21(1):65-71.
6
Medicine in small doses.小剂量用药。
ANZ J Surg. 2017 Jul;87(7-8):538. doi: 10.1111/ans.14109.
7
Medical journals and conflicts of interest.医学期刊与利益冲突。
J Law Med Ethics. 2012 Fall;40(3):488-99. doi: 10.1111/j.1748-720X.2012.00681.x.
8
Authors, industry, and review articles.作者、行业及综述文章。
J Am Coll Cardiol. 2004 Mar 17;43(6):1130-1. doi: 10.1016/j.jacc.2004.02.007.
9
Re: Regulatory Toxicology and Pharmacology.关于：《监管毒理学与药理学》
Int J Occup Environ Health. 2003 Oct-Dec;9(4):386-9; author reply 389-90. doi: 10.1179/oeh.2003.9.4.386.
10
"Good Publication Practice for Pharmaceutical Companies": where are we now?制药公司的良好出版规范：我们如今处于什么状况？
MedGenMed. 2005 Apr 18;7(2):6.
Zotero 插件